Want to join the conversation?
Specialty chemicals company $DOW posted 1Q16 net income of $275MM or $0.15 per diluted share compared to $1.2Bil or $1.18 per diluted share in 1Q15. Sales were $10.7Bil, down 13% versus the year-ago period, or 8% excluding the impact of divestitures and acquisitions. On an operating basis, EPS was $0.89 in 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?